Literature DB >> 9438375

Eukaryotic initiation factor 2B (eIF2B).

B L Webb1, C G Proud.   

Abstract

Eukaryotic initiation factor 2B (eIF2B) is a guanine nucleotide-exchange factor which mediates the exchange of GDP (bound to initiation factor eIF2) for GTP, thus regenerating the active [eIF2.GTP] complex that is required for peptide-chain initiation. The activity of eIF2B is a key control point for eukaryotic protein synthesis and is altered in response to viral infection, hormones, nutrients, growth factors and certain stresses. It may be regulated directly by its own phosphorylation, phosphorylation of its substrate, eIF2 and by allosteric effectors. Understanding its regulation will lead to a better knowledge of insulin action, regulation of the immune system and of insulin production in the pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438375     DOI: 10.1016/s1357-2725(97)00039-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

1.  Cellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2α signaling pathways and implications for autophagy.

Authors:  Jordan C Wengrod; Lawrence B Gardner
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  eIF2B Mechanisms of Action and Regulation: A Thermodynamic View.

Authors:  Andrew M Bogorad; Kai Ying Lin; Assen Marintchev
Journal:  Biochemistry       Date:  2018-02-20       Impact factor: 3.162

3.  Eukaryotic initiation factor 2B epsilon induces cap-dependent translation and skeletal muscle hypertrophy.

Authors:  David L Mayhew; Troy A Hornberger; Hannah C Lincoln; Marcas M Bamman
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

4.  The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

Authors:  Y L Woods; P Cohen; W Becker; R Jakes; M Goedert; X Wang; C G Proud
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 5.  Therapeutic interventions to disrupt the protein synthetic machinery in melanoma.

Authors:  Gregory R Kardos; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2015-09       Impact factor: 4.693

6.  The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus.

Authors:  Rachel Elsby; Joshua F Heiber; Peter Reid; Scot R Kimball; Graham D Pavitt; Glen N Barber
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

7.  Nutrients differentially regulate multiple translation factors and their control by insulin.

Authors:  L E Campbell; X Wang; C G Proud
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.

Authors:  Gregory R Kardos; Hannah C Wastyk; Gavin P Robertson
Journal:  Mol Cancer Res       Date:  2015-06-16       Impact factor: 5.852

9.  GCN2- and eIF2α-phosphorylation-independent, but ATF4-dependent, induction of CARE-containing genes in methionine-deficient cells.

Authors:  Kevin M Mazor; Martha H Stipanuk
Journal:  Amino Acids       Date:  2016-09-10       Impact factor: 3.520

10.  Activation of the mammalian target of rapamycin complex 1 is both necessary and sufficient to stimulate eukaryotic initiation factor 2Bvarepsilon mRNA translation and protein synthesis.

Authors:  Neil Kubica; Jamie L Crispino; James W Gallagher; Scot R Kimball; Leonard S Jefferson
Journal:  Int J Biochem Cell Biol       Date:  2008-05-15       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.